These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4408031)

  • 1. [Assessment of the course of a disease in the therapeutic comparison].
    Horbach L
    Arzneimittelforschung; 1974 Jul; 24(7):1001-4. PubMed ID: 4408031
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems in the use of statistical methods in therapy studies].
    Wolf GK
    Fortschr Med; 1981 Jun; 99(21):803-5, 823. PubMed ID: 7250871
    [No Abstract]   [Full Text] [Related]  

  • 3. How to read clinical journals: V: To distinguish useful from useless or even harmful therapy.
    Can Med Assoc J; 1981 May; 124(9):1156-62. PubMed ID: 7016293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introduction to the problems of clinical pharmacological research].
    Rahlfs VW
    Int J Clin Pharmacol; 1972 Nov; 6(4):385-90. PubMed ID: 4565837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical therapeutic trials].
    Mathé G
    Bull Cancer; 1974; 61(2):191-212. PubMed ID: 4619025
    [No Abstract]   [Full Text] [Related]  

  • 6. New methodology in clinical trials.
    Healy MJ
    Biometrics; 1978 Dec; 34(4):709-12. PubMed ID: 749953
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factor planning and multiple regression analysis in assessing the effectiveness of experimental therapy].
    Balashov AN
    Patol Fiziol Eksp Ter; 1979; (1):72-4. PubMed ID: 424252
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistics. Master or tool?
    Wright IS
    N Y State J Med; 1980 Mar; 80(4):605-8. PubMed ID: 6928536
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of medical practices].
    Battista RN
    Union Med Can; 1980 Oct; 109(10):1462-7. PubMed ID: 6781111
    [No Abstract]   [Full Text] [Related]  

  • 10. [The measurement parameters and statistical analysis of therapeutic study].
    Zhou ZT; Yao H
    Shanghai Kou Qiang Yi Xue; 2004 Aug; 13(4):241-5. PubMed ID: 15349653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring patient persistency with drug therapy using methods for the design and analysis of natural history studies.
    Johnson ES; Mozaffari E
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S249-54. PubMed ID: 12188167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient heterogeneity in clinical trials.
    Simon R
    Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternative clinical therapeutic evaluation].
    Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1291-6. PubMed ID: 7223006
    [No Abstract]   [Full Text] [Related]  

  • 14. Leaving therapy to chance.
    Marquis D
    Hastings Cent Rep; 1983 Aug; 13(4):40-7. PubMed ID: 6629749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The course of disease].
    Fritze E
    Methods Inf Med Suppl; 1969; 4():3-12. PubMed ID: 5294046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Summary and evaluation of the most important methodological aspects in the study of longitudinal profiles of the effects of psychopharmacological agents].
    Netter P
    Arzneimittelforschung; 1974 Jul; 24(7):1008-10. PubMed ID: 4408118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities and limitations in the objectivization of the therapeutic effect].
    Rahlfs VW
    Fortschr Med; 1973 Aug; 91(22):889-90 passim. PubMed ID: 4744892
    [No Abstract]   [Full Text] [Related]  

  • 18. Designing trials and deciding on therapy in complex diseases: what can we do to improve?
    Knaus WA
    Med Decis Making; 2005; 25(4):366-9. PubMed ID: 16061887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Testing method of rank data in the design of paired comparison].
    Li FL
    Zhonghua Yu Fang Yi Xue Za Zhi; 1983 Nov; 17(6):336-8. PubMed ID: 6675982
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating risks and benefits in AIDS vaccine and drug trials.
    Kessel E
    AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.